Fresenius Accelerates Momentum in its (Bio)Pharma Business and Launches Tyenne®*, its Third Approved Biosimilar in the U.S.
Tyenne® is the first tocilizumab biosimilar by Fresenius Kabi, an operating company of Fresenius, with an intravenous an…
Tyenne® is the first tocilizumab biosimilar by Fresenius Kabi, an operating company of Fresenius, with an intravenous an…
Within the realm of modern technology, cameras have progressed from mere devices capturing visible light to sophisticate…
BASF has broken ground on the new fermentation plant for biological and biotechnology-based crop protection products in…
Enhancers are genetic elements that control when and where genes are expressed in many living systems and genetic differ…
EpiLogic GmbH and Tentamus India have joined forces to offer the services of EpiLogic in India. EpiLogic is currently th…
Messenger RNA (mRNA) nanomedicines, a ground-breaking technology that has led to the development of the first approved C…
Portfolio ranges from standard rolling bearings to customized drive solutions Schaeffler’s OPTIME Ecosystem makes m…
. Rapid.Tech 3D 9 – 11 May 2023, Messe Erfurt, Germany The exhibition and award ceremony of the eighth edition of the…
CeGaT, a global provider of sequencing services for research, clinical studies, and human genetic diagnostics, is now us…
Tentamus Group is proud to welcome CONIDIA CONIPHY as its newest member of the global network of laboratories. CONIDIA C…